Loading...
XPAR
GDS
Market cap1.16bUSD
Dec 05, Last price  
9.00EUR
1D
-0.44%
1Q
-9.64%
Jan 2017
-38.38%
IPO
-51.51%
Name

Ramsay Generale de Sante SA

Chart & Performance

D1W1MN
XPAR:GDS chart
P/E
—
P/S
0.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
6.95%
Revenues
5.24b
+4.70%
1,435,500,0001,741,500,0001,906,000,0001,983,800,0002,046,200,0001,926,100,0001,955,000,0001,928,600,0001,869,700,0001,711,600,0002,226,900,0002,234,400,0002,241,500,0003,401,100,0003,746,200,0004,022,600,0004,301,000,0004,701,500,0005,006,500,0005,242,000,000
Net income
-54m
L+0.37%
40,900,000225,400,00045,600,00087,200,00042,400,00037,900,000-28,500,00055,700,000111,300,00019,700,00036,900,00057,000,0007,300,00015,300,00018,700,00065,000,000118,400,00049,400,000-53,900,000-54,100,000
CFO
694m
+18.22%
154,900,000152,600,000179,600,000253,300,000149,000,000194,100,000172,400,000206,700,000151,300,000159,000,000196,000,000209,400,000213,900,000213,600,000729,600,000652,300,000262,500,000598,900,000586,800,000693,700,000
Dividend
Dec 02, 20140.791344 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
URL
https://www.ramsaysante.fr/
IPO date
Jun 19, 2001
Employees
36,000
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT